Table 1:
Patient Characteristics
| 80+ (n = 2,155) | 70–79 (n = 2,933) | P | |
|---|---|---|---|
| Gender | |||
| Male | 45% | 53% | < .0001 |
| Female | 55% | 47% | |
| Race | |||
| White/Caucasian | 81% | 77% | .0013 |
| Black/African-American | 13% | 16% | |
| Other | 7% | 7% | |
| Charlson Comorbidity Index Score (mean±standard deviation) | 2.27±2.02 | 1.95±2.01 | < .0001 |
| Poor Performance Status Indicator | 32% | 19% | < .0001 |
| Medicaid Enrollment | 28% | 31% | .0570 |
| Myeloma“CRAB” Criteria | |||
| Hypercalcemia | 22% | 22% | .7051 |
| Renal Impairment | 61% | 55% | < .0001 |
| Anemia | 59% | 63% | .0019 |
| Bone Involvement | 34% | 35% | .8843 |
| Received anti-myeloma treatment | 51% | 71% | < .0001 |
| Year of Diagnosis | |||
| 2007 | 12% | 13% | .6628 |
| 2008 | 13% | 13% | |
| 2009 | 14% | 13% | |
| 2010 | 13% | 14% | |
| 2011 | 15% | 15% | |
| 2012 | 16% | 17% | |
| 2013 | 16% | 16% | |